DK3114215T3 - Grupperede nk-celler fra navlestrengsblod og anvendelse deraf til behandling af cancer og kronisk infektionssygdom - Google Patents
Grupperede nk-celler fra navlestrengsblod og anvendelse deraf til behandling af cancer og kronisk infektionssygdom Download PDFInfo
- Publication number
- DK3114215T3 DK3114215T3 DK15709149.7T DK15709149T DK3114215T3 DK 3114215 T3 DK3114215 T3 DK 3114215T3 DK 15709149 T DK15709149 T DK 15709149T DK 3114215 T3 DK3114215 T3 DK 3114215T3
- Authority
- DK
- Denmark
- Prior art keywords
- grouped
- cancer
- cells
- treatment
- umbilical cord
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 208000037581 Persistent Infection Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 210000004700 fetal blood Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
- A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/15—Natural-killer [NK] cells; Natural-killer T [NKT] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2302—Interleukin-2 (IL-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2315—Interleukin-15 (IL-15)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Virology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14305332 | 2014-03-07 | ||
| PCT/EP2015/054837 WO2015132415A1 (en) | 2014-03-07 | 2015-03-09 | Pooled nk cells from ombilical cord blood and their uses for the treatment of cancer and chronic infectious disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3114215T3 true DK3114215T3 (da) | 2021-06-21 |
Family
ID=50277168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15709149.7T DK3114215T3 (da) | 2014-03-07 | 2015-03-09 | Grupperede nk-celler fra navlestrengsblod og anvendelse deraf til behandling af cancer og kronisk infektionssygdom |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20170073637A1 (https=) |
| EP (1) | EP3114215B1 (https=) |
| JP (2) | JP6775426B2 (https=) |
| CN (1) | CN106164256B (https=) |
| CA (1) | CA2941519C (https=) |
| DK (1) | DK3114215T3 (https=) |
| ES (1) | ES2880718T3 (https=) |
| WO (1) | WO2015132415A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017042393A1 (en) * | 2015-09-11 | 2017-03-16 | Emercell Sas | Pooled nk cells from umbilical cord blood associated with antibodies and their uses for the treatment of disease |
| CA3003923A1 (en) * | 2015-11-05 | 2017-05-11 | Glycostem Therapeutics B.V. | Composition for use in immunotherapy |
| AU2017213659B2 (en) * | 2016-02-05 | 2024-04-18 | Washington University | Compositions and methods for targeted cytokine delivery |
| IL276365B2 (en) * | 2018-02-01 | 2023-10-01 | Nkmax Co Ltd | A method for the production of natural killer cells and a preparation for cancer treatment |
| EP3755347B1 (en) * | 2018-02-21 | 2025-06-25 | Board of Regents, The University of Texas System | Universal antigen presenting cells and uses thereof |
| US12473336B2 (en) | 2018-02-21 | 2025-11-18 | Board Of Regents, The University Of Texas System | Methods for activation and expansion of natural killer cells and uses thereof |
| HRP20240821T1 (hr) | 2018-08-27 | 2024-09-27 | Affimed Gmbh | Stanice nk čuvane zamrzavanjem, koje su prethodno ubačene uz protutijelni konstrukt |
| WO2020152661A1 (ja) * | 2019-01-21 | 2020-07-30 | 株式会社ガイアバイオメディシン | Ｎｋ細胞を含む細胞集団の製造方法 |
| JP6838750B2 (ja) * | 2019-01-21 | 2021-03-03 | 株式会社ガイアバイオメディシン | Ｎｋ細胞を含む細胞集団の製造方法 |
| JP6977969B2 (ja) * | 2019-03-22 | 2021-12-08 | 株式会社ガイアバイオメディシン | 免疫細胞提供システム |
| JP2021035400A (ja) * | 2020-12-07 | 2021-03-04 | 株式会社ガイアバイオメディシン | Ｎｋ細胞を含む細胞集団の製造方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101077912B1 (ko) * | 2008-10-24 | 2011-10-31 | 주식회사 메디셀 | 제대혈로부터 효율적인 자연살해세포의 증식 및 분화 방법 |
| CA2703428A1 (en) * | 2010-05-11 | 2011-11-11 | Mcgill University Health Center | Pooled cord blood units |
| ES2666746T3 (es) * | 2010-07-13 | 2018-05-07 | Anthrogenesis Corporation | Métodos para generar linfocitos citolíticos naturales |
| KR101447546B1 (ko) * | 2011-03-03 | 2014-10-08 | 한국생명공학연구원 | 제대혈 ｃｄ14 양성 단핵세포로부터 자연살해세포 분화 및 증식 방법 |
| EP2702145A1 (en) * | 2011-04-28 | 2014-03-05 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Methods for preparing accessory cells and uses thereof for preparing activated nk cells |
| JP5840876B2 (ja) * | 2011-06-24 | 2016-01-06 | テラ株式会社 | Ｎｋ細胞を増幅するための組成物及び方法 |
| JP5572863B2 (ja) * | 2011-06-24 | 2014-08-20 | 国立大学法人九州大学 | Ｎｋ細胞の増幅方法 |
| CN115137753A (zh) * | 2013-02-05 | 2022-10-04 | 细胞结构公司 | 来自胎盘的自然杀伤细胞 |
-
2015
- 2015-03-09 EP EP15709149.7A patent/EP3114215B1/en active Active
- 2015-03-09 US US15/123,660 patent/US20170073637A1/en active Pending
- 2015-03-09 WO PCT/EP2015/054837 patent/WO2015132415A1/en not_active Ceased
- 2015-03-09 CA CA2941519A patent/CA2941519C/en active Active
- 2015-03-09 CN CN201580011900.9A patent/CN106164256B/zh active Active
- 2015-03-09 JP JP2016572917A patent/JP6775426B2/ja active Active
- 2015-03-09 DK DK15709149.7T patent/DK3114215T3/da active
- 2015-03-09 ES ES15709149T patent/ES2880718T3/es active Active
-
2020
- 2020-04-10 JP JP2020071370A patent/JP2020114248A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017508479A (ja) | 2017-03-30 |
| WO2015132415A1 (en) | 2015-09-11 |
| EP3114215B1 (en) | 2021-04-14 |
| CA2941519C (en) | 2022-09-06 |
| JP2020114248A (ja) | 2020-07-30 |
| CA2941519A1 (en) | 2015-09-11 |
| CN106164256A (zh) | 2016-11-23 |
| EP3114215A1 (en) | 2017-01-11 |
| ES2880718T3 (es) | 2021-11-25 |
| CN106164256B (zh) | 2021-08-10 |
| US20170073637A1 (en) | 2017-03-16 |
| JP6775426B2 (ja) | 2020-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285965A (en) | Ex vivo organ care system | |
| IL296080B1 (en) | Method for treating cancer | |
| DK3114215T3 (da) | Grupperede nk-celler fra navlestrengsblod og anvendelse deraf til behandling af cancer og kronisk infektionssygdom | |
| IL290993A (en) | Methods of diagnosing and treating tourette syndrome | |
| IL280899A (en) | Heterocyclic compounds for cancer imaging and treatment and methods for their use | |
| EP3600509A4 (en) | Patient interface | |
| DK3202305T3 (da) | Engangsendoskop og system | |
| IL255261A0 (en) | Methods for treating cancer | |
| DK3191020T3 (da) | Medicinsk/kirurgisk implantat | |
| IL255312A0 (en) | Therapeutic and diagnostic methods for cancer | |
| EP3448485A4 (en) | PATIENT INTERFACE | |
| IL247777B (en) | Ablation catheter and ablation apparatus | |
| LT3277842T (lt) | Vėžio pacientų gydymo būdai farneziltransferazės inhibitoriais | |
| EP3522966A4 (en) | PATIENT INTERFACES | |
| DK3757206T3 (da) | Transduktionsfremgangsmåde og cellebehandling | |
| DK3590543T3 (da) | Medicinsk forbinding | |
| BR112016030398A2 (pt) | Instrumento cirúrgico endoscópico | |
| DK3197354T3 (da) | Medicinsk anordning | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| HUE038541T2 (hu) | Rák kezelési módszerek | |
| HUE050944T2 (hu) | Kezelési eljárás tradipitant alkalmazásával | |
| DK3678714T3 (da) | Vævsmanipuleret medicinsk indretning | |
| IL256103B (en) | Compositions and methods for treating celiac sprue disease | |
| IL250110B (en) | Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer | |
| EP3445431A4 (en) | PATIENT INTERFACE AND ASPECTS THEREOF |